Latest Healthcare Product Pricing News

Page 1 of 1

Medical Developments Reports Strong Q2 FY25 Cash Flow and Revenue Growth

Medical Developments International has posted a robust improvement in operating cash flow and revenue for Q2 FY25, driven by higher demand and pricing for its flagship product Penthrox across Australia and Europe.

Ada Torres

31 Jan 2025

Browse the archive

Full archive

Aug 2026 July 2026 June 2026 May 2026 Apr 2026 Mar 2026 Feb 2026 Jan 2026